TCL Archive Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease February 22, 2013
TCL Archive In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents May 8, 1981